Advances in pathogenic concepts and therapeutic agents in Rasmussen’s encephalitis

Bibliography

• RASMUSSEN T, OLSZEWSKI J, LLOYD-SMITH D: Focal seizures due to chronic localized encephalitis. Neurology (1958) 8:435–445.
   PubMed Web of Science ®Google Scholar
• HART Y, ANDERMANN, F: Rasmussensyndrome. In: Intractable Focal Epilepsy Oxbury JM, Polkey CE, Duchowny M (eds). W. B. Saunders, London, UK (2000):233–248.
   Google Scholar
• BIEN CG, WIDMAN G, URBACH H, SASSEN R, KUCZATY S, WIESTLER OD, SCHRAMM J, ELGER CE: The natural history of Rasmussen's encephalitis. Brain: In press.
   Google Scholar
• VILLANI F, SPREAFICO R, FARINA L et al.: Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology (2001) 56:248–250.
   PubMed Web of Science ®Google Scholar
• KOSHEWNIKOW AJ: Eine besondere Form von corticaler Epilepsie. Nem& Central& (1895) 14 :47–48.
   Google Scholar
• MCLACHLAN RS, GIRVIN JP, BLUME WT, REICHMAN H: Rasmussen's chronic encephalitis in adults. Arch. Near& (1993) 50:269–274.
   PubMed Web of Science ®Google Scholar
• HART YM, ANDERMANN F, FISH DRet al.: Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen's syndrome? Neurology (1997) 48:418–424.
   Google Scholar
• VADLAMUDI L, GALTON CJ, JEAVONSSJ, TANNENBERG AE, BOYLE RS: Rasmussen's syndrome in a 54 year old female: more support for an adult variant. Clin. Neurosci. (2000) 7:154–156.
   Google Scholar
• BIEN CG, URBACH H, DECKERT M et al.: Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology (2002) 58:250–257.
   PubMed Web of Science ®Google Scholar
• OGUNI H, ANDERMANN F, RASMUSSEN TB: The syndrome of chronic encephalitis and epilepsy. A study based on the MNI series of 48 cases. Adv. Nem& (1992) 57:419–433.
   Google Scholar
• ROBITAILLE Y: Neuropathologic aspects ofchronic encephalitis. In: Chronic encephalitic and epilepsy Rasmussen's syndrome. Andermann F (ed). Butterworth-Heinemann, Boston, USA (1991):79–110.
   Google Scholar
• VILLEMURE J-G, ANDERMANN, F, RASMUSSEN, TB: Hemispherectomy for the treatment of epilepsy due to chronic encephalitis. In: Chronic encephalitic and epilepsy: Rasmussen's syndrome, Andermann F (ed). Butterworth-Heinemann, Boston, USA (1991):235–241.
   Google Scholar
• HONAVAR M, JANOTA I, POLKEY CE: Rasmussen's encephalitis in surgery for epilepsy. Dev. Med. Child Neurol. (1992) 34:3–14.
   PubMed Web of Science ®Google Scholar
• SCHRAMM J, BEHRENS E, ENTZIAN W: Hemispherical deafferentation: an alternative to functional hemispherectomy. Neurosurgery (1995) 36:509–515.
   PubMed Web of Science ®Google Scholar
• SCHRAMM J, KRAL T, CLUSMANN H: Transsylvian keyhole functional hemispherectomy. Neurosurgery (2001) 49:891–900.
   PubMed Web of Science ®Google Scholar
• RASMUSSEN T: Heinispherectomy for seizures revisited. Can. J. Neural. Sci. (1993) 10:71–78.
   Google Scholar
• PIATT JH, JR., HWANG PA, ARMSTRONG DC, BECKER LE, HOFFMAN HJ: Chronic focal encephalitis (Rasmussen syndrome): six cases. Epilepsia (1988) 29:268–279.
   PubMed Web of Science ®Google Scholar
• DUBEAU F, SHERWIN AL: Pharmacologic principles in the managment of chronic focal encephalitis. In: Chronic encephalitic and epilepsy: Rasmussen's syndrome. Andermann F (ed.). Butterworth-Heinemann, Boston, USA (1991):179–192.
   Google Scholar
• TOPCU M, TURANLI G, AYNACI FM et al.: Rasmussen encephalitis in childhood. Childs. Nerv. Syst. (1999) 15:395-402; discussion 403.
   Google Scholar
• THOMAS JE, REAGAN TJ, KLASS DW: Epilepsia partialis continua. A review of 32 cases. Arch. Neurol (1977) 34:266–275.
   PubMed Web of Science ®Google Scholar
• OBESO JA, ROTHWELL JC, MARSDEN CD: The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy. Bradt (1985) 108:193–224.
   Google Scholar
• COCKERELL OC, ROTHWELL J, THOMPSON PD, MARSDEN CD, SHORVON SD: Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK. Bradt (1996) 119:393–407.
   Google Scholar
• BROWN P, STEIGER MJ, THOMPSON PD et al.: Effectiveness of piracetam in cortical myoclonus. Mov. Disord. (1993) 8:63–68.
   PubMed Web of Science ®Google Scholar
• IKEDA A, SHIBASAKI H, TASHIRO K, MIZUNO Y, KIMURA J: Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group. Mo v. Disord. (1996) 11:691–700.
   PubMed Web of Science ®Google Scholar
• KOSKINIEMI M, VAN VLEYMEN B, HAKAMIES L, LAMUSUO S, TAALAS J: Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo. J. Neurol Neurosurg. Psychiatry (1998) 64:344–348.
   PubMed Web of Science ®Google Scholar
• GENTON P, GELISSE P: Antimyoclonic effect of levetiracetam. Epileptic. Disord. (2000) 2:209–212.
   PubMed Web of Science ®Google Scholar
• FRUCHT SJ, LOUIS ED, CHUANG C, FAHN S: A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology (2001) 57:1112–1114.
   PubMed Web of Science ®Google Scholar
• ASHER DM, GAJDUSEK, DC: Vicologic studies in chronic encephalitis. In: Chronic encephalitic and epilepsy Rasmussen's syndrome. Andermann F (ed). Butterworth-Heinemann, Boston, USA (1991):147–158.
   Google Scholar
• OMOROKOW LI: Die Kojevnikoffsche Epilepsie in Sibirien. Zschr Ges. Neurol. Psychiat. (1927) 107:487–496.
   Google Scholar
• FRIEDMAN H, CH'IEN L, PARHAM D: Virus in brain of child with hemiplegia, hemiconvulsions, and epilepsy. Lancet (1977) 2:666–
   PubMed Web of Science ®Google Scholar
• WALTER GF, RENELLA RR: Epstein-Barr virus in brain and Rasmussen's encephalitis [letter]. Lancet (1989) 1:279–280.
   PubMed Web of Science ®Google Scholar
• POWER C, POLAND SD, BLUME WT, GIRVIN JP, RICE GP: Cytomegalovirus and Rasmussen's encephalitis. Lancet (1990) 336:1282–1284.
   PubMed Web of Science ®Google Scholar
• JAY V, BECKER LE, OTSUBO H et al: Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology (1995) 45:108–117.
   PubMed Web of Science ®Google Scholar
• RASMUSSEN T: Further observations on the syndrome of chronic encephalitis and epilepsy. Appl Neurophysiol (1978) 41:1–12.
   PubMedGoogle Scholar
• FARRELL MA, CHENG L, CORNFORD ME, GRODY WW, VINTERS HV: Cytomegalovirus and Rasmussen's encephalitis [letter; comment]. Lancet (1991) 337:1551–1552.
   PubMed Web of Science ®Google Scholar
• VINTERS HV, WANG R, WILEY CA: Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy. Hum. Pathol (1993) 24:871–879.
   PubMed Web of Science ®Google Scholar
• ATKINS MR, TERRELL W, HULETTE CM: Rasmussen's syndrome: a study of potential viral etiology. Clin. Neuropathol (1995) 14:7–12.
   PubMed Web of Science ®Google Scholar
• GILDEN DH, LIPTON H: Cytomegalovirus and Rasmussen's encephalitis [letter; comment]. Lancet (1991) 337:239–
   Web of Science ®Google Scholar
• MCLACHLAN RS, LEVIN S, BLUME WT: Treatment of Rasmussen's syndrome with ganciclovir. Neurology (1996) 47:925–928.
   PubMed Web of Science ®Google Scholar
• ANDREWS JM, THOMPSON JA, PYSHER TJ, WALKER ML, HAMMOND ME: Chronic encephalitis, epilepsy, and cerebrovascular immune complex deposits. Ann. Neurol (1990) 28:88–90.
   PubMed Web of Science ®Google Scholar
• ROGERS SW, ANDREWS PI, GAHRING LC et al.: Autoantibodies to glutamate receptor G1uR3 in Rasmussen's encephalitis. Science (1994) 265:648–651.
   PubMed Web of Science ®Google Scholar
• HE XP, PATEL M, WHITNEY KD, JANUMPALLI S, TENNER A, MCNAMARA JO: Glutamate receptor G1uR3 antibodies and death of cortical cells. Neuron (1998) 20:153–163.
   PubMed Web of Science ®Google Scholar
• TWYMAN RE, GAHRING LC, SPIESS J,ROGERS SW: Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron (1995) 14:755–762.
   PubMed Web of Science ®Google Scholar
• LEVITE M, FLEIDERVISH IA, SCHWARZ A, PELLED D, FUTERMAN AH: Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J. Autoimmun. (1999) 13:61–72.
   PubMed Web of Science ®Google Scholar
• WHITNEY KD, ANDREWS JM, MCNAMARA JO: Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis. Neurology (1999) 53:699–708.
   PubMed Web of Science ®Google Scholar
• ANDREWS PI, DICHTER MA, BERKOVIC SF, NEWTON MR, MCNAMARA JO: Plasmapheresis in Rasmussen's encephalitis. Neurology (1996) 46:242–246.
   PubMed Web of Science ®Google Scholar
• PALCOUX JB, CARLA H, TARDIEU M et al.: Plasma exchange in Rasmussen's encephalitis. Ther. Apher. (1997) 1:79–82.
   PubMedGoogle Scholar
• ANTOZZI C, GRANATA T, AURISANO N et al.: Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. Neurology (1998) 51:302–305.
   PubMed Web of Science ®Google Scholar
• WIENDL H, BIEN CG, BERNASCONI P et al.: G1uR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology (2001) 57:1511–1514.
   PubMed Web of Science ®Google Scholar
• ••This article shows that anti-GluR3antibodies are not specific for RE, but are also found in other forms of epilepsy.
   Google Scholar
• BARANZINI SE, LAXER K, SAKETKHOO R et al: Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis. Neurology (2002) 58:709–716.
   PubMed Web of Science ®Google Scholar
• YANG R, PURANAM RS, BUTLER LS et al.: Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron (2002) 28:375–383.
   Web of Science ®Google Scholar
• GAHRING LC, CARLSON NG, MEYER EL, ROGERS SW: Cutting Edge: Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. Immunol. (2001) 166:1433–1438.
   Web of Science ®Google Scholar
• •This article describes how specific cleavage of inefficiently glycosylated GluR3 by GrB, a serine protease released by cytotoxic T lymphocytes, can generate the G1uR3B autoantigenic peptide, which upon release may induce an anti-G1uR3 antibody response.
   Google Scholar
• CHINCHILLA D, DULAC 0, ROBAIN 0 et al.: Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids. J. Neurol Neurosurg. Psychiatry (1994) 57:1325–1333.
   Google Scholar
• HART YM, CORTEZ M, ANDERMANN F et al.: Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology (1994) 44:1030–1036.
   PubMed Web of Science ®Google Scholar
• •This article contains the largest sample of conservatively treated RE patients.
   Google Scholar
• WALSH PJ: Treatment of Rasmussen's syndrome with intravenous gammaglobulin. In: Chronic encephalitic and epilepsy Rasmussen's syndrome. Andermann F (ed). Butterworth-Heinemann, Boston, USA (1991):201–204.
   Google Scholar
• WISE MS, RUTLEDGE SL, KUZNIECKY RI: Rasmussen syndrome and long-term response to gamma globulin. Pediatr. Neurol (1996) 14:149–152.
   PubMed Web of Science ®Google Scholar
• LEACH JP, CHADWICK DW, MILES JB, HART IK: Improvement in adult-onset Rasmussen's encephalitis with long- term immunomodulatory therapy. Neurology (1999) 52:738–742.
   PubMed Web of Science ®Google Scholar
• KRAUSS GL, CAMPBELL ML, ROCHE KW, HUGANIR RL, NIEDERMEYER E: Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor G1uR3. Neurology(1996) 46:247–249.
   PubMed Web of Science ®Google Scholar
• VINJAMURI S, LEACH JP, HART IK: Serial perfusion brain tomographic scans detect reversible focal ischaemia in Rasmussen's encephalitis. Postgrad. Med. J. (2000) 76:33–35.
   PubMed Web of Science ®Google Scholar
• MARIA BL, RINGDAHL DM, MICKLE JP et al.: Intraventricular alpha interferon therapy for Rasmussen's syndrome. Can. J. Neurol Sci. (1993) 20:333–336.
   PubMed Web of Science ®Google Scholar
• DABBAGH 0, GASCON G, CROWELL J,BAMOGGADAM F: Intraventricular interferon-alpha stops seizures in Rasmussen's encephalitis: a case report. Epilepsia (1997) 38:1045–1049.
   PubMed Web of Science ®Google Scholar
• FARRELL MA, DROOGAN 0, SECOR DL, POUKENS V, QUINN B, VINTERS HV: Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol Berl. (1995) 89:313–321.
   PubMed Web of Science ®Google Scholar
• LI Y, UCCELLI A, LAXER KD et al: Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J. Immunol (1997) 158:1428–1437.
   PubMed Web of Science ®Google Scholar
• BIEN CG, BAUER J, DECKWERTH TL et al.: Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis.Ann. Neurol (2002) 51:311–318.
   PubMed Web of Science ®Google Scholar
• ••This article firstly shows that cytotoxicT cells in pathological lesions in RE are in direct contact with neurons. Neurons express MHC class I molecules and CD8 cytotoxic T cells contain GrB-positive granules in a polarised-position towards neurons. Neurons in these lesions died by apoptosis, thus together proposing a new pathogenic mechanism in Rasmussen's encephalitis.
   Google Scholar
• KAZATCHKINE MD, KAVERI SV: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl. I Med. (2001) 345:747–755.
   PubMed Web of Science ®Google Scholar
• ALBERT ML, AUSTIN LM, DARNELL RB: Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann. Neurol (2000) 47:9–17.
   PubMed Web of Science ®Google Scholar
• DETOLEDO JC, SMITH DB: Partially successful treatment of Rasmussen's encephalitis with zidovudine: symptomatic improvement followed by involvement of the contralateral hemisphere. Epilepsia (1994) 35:352–355.
   PubMed Web of Science ®Google Scholar